MaxQ

MaxQ, founded in 2013, has its headquarters in both Massachusetts, USA, and Tel Aviv, Israel. It aims to provide decision support based on artificial intelligence technology for medical service providers and personnel to improve clinical outcomes in acute care scenarios. Currently, the company has entered the A-round financing stage, raising a total of approximately $9 million through three rounds of financing, with Exigent Capital as its main supporter.MaxQ-AI’s ACCIPIO® ICH and Stroke platform with INSIGHT™ is integrated into a comprehensive, seamless, and secure workflow, enabling emergency teams to expand their capabilities with profound clinical insights and actionable data within minutes. It will support radiology, emergency departments, neuroradiology, and stroke teams. The Accipio Ix™ platform offers tools for automatic identification/detection, notification, acceleration, and prioritization of suspected ICH cases.